DJIA 16,804.71 -238.19 -1.40%
NASDAQ 4,422.09 -71.31 -1.59%
S&P 500 1,946.16 -26.13 -1.32%
market minute promo

155.30 -5.26 (-3.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JAZZ $155.30 -3.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $160.82
Previous Close $160.56
Daily Range $153.50 - $161.18
52-Week Range $80.40 - $176.60
Market Cap $9.4B
P/E Ratio 124.47
Dividend (Yield) $0.00 (0.0%)
Volume 742,371
Average Daily Volume 999,113
Current FY EPS $7.40





Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary

Should You Invest in Corporate Tax Inversions?

Despite the controversy regarding whether corporate inversions are right or wrong, investors are looking to make money from them. Has Motif Investing put together a way for small investors to profit from tax inversions?

Why I Am Still Bullish On Jazz Pharmaceuticals

Shire Resolves Litigation Related to Vyvanse, Adderall XR - Analyst Blog

OPKO Health (OPK) Reports Positive Data on Rayaldee Trial - Analyst Blog

Alcobra Finishes Follow-up Visits on Phase III Trial on MDX - Analyst Blog

Dynavax (DVAX) Completes Enrolment for Study on Heplisav - Analyst Blog

Insider Trading Alert - TDC, MJN And JAZZ Traded By Insiders

Jazz Pharmaceuticals (JAZZ) in Focus: Stock Rises 7.1% - Tale of the Tape

Jazz Pharmaceuticals (JAZZ) in Focus: Stock Rises 7.1% - Tale of the Tape

Pfizer: You Won't Fool Me Twice

Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $155.30 (-3.28%)
Current stock: JAZZ
JNJ $104.30 (-2.15%)
Current stock: JNJ
PFE $29.15 (-1.42%)
Current stock: PFE
NVS $93.22 (-0.97%)
Current stock: NVS